Cell Marque anti-NSE (MRQ-55) Mouse Monoclonal Primary Antibody - HSA Registration DE0508932
Access comprehensive regulatory information for Cell Marque anti-NSE (MRQ-55) Mouse Monoclonal Primary Antibody in the Singapore medical device market through Pure Global AI's free database. This CLASS B IVD medical device is registered under HSA registration number DE0508932 and owned by Cell Marque Corporation. The device was registered on February 06, 2024.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
NSE (MRQ-55) Mouse Monoclonal Primary Antibody is intended for laboratory use in the detection of the NSE enzyme in formalin-fixed, paraffin-embedded tissue stained on VENTANA BenchMark IHC/ISH instruments. This product should be interpreted by a qualified pathologist in conjunction with histological examination, relevant clinical information, and proper controls. This antibody is intended for in vitro diagnostic (IVD) use.